Clinical Endocrinology

Inhibins and activins: clinical advances in reproductive medicine
pp. 115-127(13)
Authors: Tong, Stephen; Wallace, Euan M.; Burger, Henry G.

Inhibins and activins: clinical advances in reproductive medicine
pp. 115-127
Authors: Tong S.; Wallace E.M.; Burger H.G.

Radiotherapy in acromegaly: a protagonists viewpoint
pp. 128-131(4)
Author: Wass, J. A. H.

Radiotherapy in acromegaly: a protagonists viewpoint
pp. 128-131
Author: Wass J.A.H.

Radiotherapy in acromegaly: the argument against
pp. 132-135(4)
Author: Barkan, Ariel L.

Radiotherapy in acromegaly: the argument against
pp. 132-135
Author: Barkan A.L.

Controversy: radiotherapy for acromegaly
pp. 136-137(2)
Author: Thorner, Michael O.

Controversy: radiotherapy for acromegaly
pp. 136-137
Author: Thorner M.O.

Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease
pp. 138-140(3)
Authors: Demers, L. M.; Spencer, C. A.

Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease
pp. 138-140
Authors: Demers L.M.; Spencer C.A.

Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour
pp. 141-150(10)
Authors: McCabe, C. J.; Khaira, J. S.; Boelaert, K.; Heaney, A. P.; Tannahill, L. A.; Hussain, S.; Mitchell, R.; Olliff, J.; Sheppard, M. C.; Franklyn, J. A.; Gittoes, N. J. L.

Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour
pp. 141-150
Authors: McCabe C.J.; Khaira J.S.; Boelaert K.; Heaney A.P.; Tannahill L.A.; Hussain S.; Mitchell R.; Olliff J.; Sheppard M.C.; Franklyn J.A.; Gittoes N.J.L.

Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas
pp. 151-155(5)
Authors: Kanakis, D.; Kirches, E.; Mawrin, C.; Dietzmann, K.

Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas
pp. 151-155
Authors: Kanakis D.; Kirches E.; Mawrin C.; Dietzmann K.

Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test
pp. 156-162(7)
Authors: van Dam, P. Sytze; Dieguez, Carlos; Cordido, Fernando; de Vries, Wouter R.; Veldhuyzen, Bernard F. E.; van Thiel, E.; F. Casanueva, Felipe; Koppeschaar, Hans P. F.

Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test
pp. 156-162
Authors: van Dam P.S.; Dieguez C.; Cordido F.; de Vries W.R.; Veldhuyzen B.F.E.; van Thiel E.; F. Casanueva F.; Koppeschaar H.P.F.

Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets
pp. 163-168(6)
Authors: Mäkitie, Outi; Kooh, Sang Whay; Sochett, Etienne

Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets
pp. 163-168
Authors: Mäkitie O.; Kooh S.W.; Sochett E.

Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide
pp. 169-176(8)
Authors: Colao, Annamaria; Marzullo, Paolo; Cuocolo, Alberto; Spinelli, Letizia; Pivonello, Rosario; Bonaduce, Domenico; Salvatore, Marco; Lombardi, Gaetano

Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide
pp. 169-176
Authors: Colao A.; Marzullo P.; Cuocolo A.; Spinelli L.; Pivonello R.; Bonaduce D.; Salvatore M.; Lombardi G.

Endocrine profiles and semen quality in spinal cord injured men
pp. 177-184(8)
Authors: Naderi, A. R.; Safarinejad, M. R.

Endocrine profiles and semen quality in spinal cord injured men
pp. 177-184
Authors: Naderi A.R.; Safarinejad M.R.

Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization
pp. 185-191(7)
Authors: Raber, Wolfgang; Gessl, Alois; Nowotny, Peter; Vierhapper, Heinrich

Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization
pp. 185-191
Authors: Raber W.; Gessl A.; Nowotny P.; Vierhapper H.

Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy
pp. 192-198(7)
Authors: Terwee, Caroline B.; Dekker, Friedo W.; Bonsel, Gouke J.; Heisterkamp, Siem H.; Prummel, Mark F.; Baldeschi, Lelio; Wiersinga, Wilmar M.

Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves’ ophthalmopathy
pp. 192-198
Authors: Terwee C.B.; Dekker F.W.; Bonsel G.J.; Heisterkamp S.H.; Prummel M.F.; Baldeschi L.; Wiersinga W.M.

Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation
pp. 199-206(8)
Authors: Cetani, Filomena; Pardi, Elena; Borsari, Simona; Tonacchera, Massimo; Morabito, Eugenia; Pinchera, Aldo; Marcocci, Claudio

Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation
pp. 199-206
Authors: Cetani F.; Pardi E.; Borsari S.; Tonacchera M.; Morabito E.; Pinchera A.; Marcocci C.

Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis
pp. 207-212(6)
Authors: Sorvillo, Francesca; Mazziotti, Gherardo; Carbone, Antonella; Morisco, Filomena; Cioffi, Michele; Rotondi, Mario; Stornaiuolo, Gianfranca; Amato, Giovanni; Gaeta, Giovanni B.; Caporaso, Nicola; Carella, Carlo

Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis
pp. 207-212
Authors: Sorvillo F.; Mazziotti G.; Carbone A.; Morisco F.; Cioffi M.; Rotondi M.; Stornaiuolo G.; Amato G.; Gaeta G.B.; Caporaso N.; Carella C.

Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected
pp. 213-219(7)
Authors: Gómez, José Manuel; Maravall, Francisco Javier; Gómez, Núria; Navarro, Miguel Angel; Casamitjana, Roser; Soler, Juan

Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected
pp. 213-219
Authors: Gómez J.M.; Maravall F.J.; Gómez N.; Navarro M.A.; Casamitjana R.; Soler J.

Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity
pp. 220-228(9)
Authors: Grottoli, S.; Gauna, C.; Tassone, F.; Aimaretti, G.; Corneli, G.; Wu, Z.; Strasburger, C. J.; Dieguez, C.; Casanueva, F. F.; Ghigo, E.; Maccario, M.

Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity
pp. 220-228
Authors: Grottoli S.; Gauna C.; Tassone F.; Aimaretti G.; Corneli G.; Wu Z.; Strasburger C.J.; Dieguez C.; Casanueva F.F.; Ghigo E.; Maccario M.

Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
pp. 229-237(9)
Authors: Rogol, Alan D.; Blethen, Sandra L.; Sy, Judy P.; Veldhuis, Johannes D.

Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
pp. 229-237
Authors: Rogol A.D.; Blethen S.L.; Sy J.P.; Veldhuis J.D.

The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing
pp. 238-245(8)
Authors: Lissett, Catherine A.; Shalet, Stephen M.

The insulin-like growth factor-I generation test: peripheral responsiveness to growth hormone is not decreased with ageing
pp. 238-245
Authors: Lissett C.A.; Shalet S.M.

Different effectiveness of cyproterone acetate doses in treatment of acne
pp. 246-246(1)

Letters to the Editors
pp. 246-247

Molecular analysis of the 21-hydroxylase gene
pp. 247-247(1)